Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • SWISS eHealth Barometer 2018

New data on the electronic patient dossier document departure

    • Congress Reports
    • News
    • Prevention and health care
    • RX
    • Studies
  • 4 minute read

The new eHealth Barometer 2018 was presented at the SWISS eHealth Forum in Bern: There is movement in the topic of digitalization of healthcare. The players are networking, the stakeholders of the Electronic Patient Dossier are open-minded.

The majority of the healthcare professionals surveyed would recommend an EPD today (Fig. 1) . Most of the healthcare providers surveyed think the EPD is a good thing, with pharmacists standing out the most, which Golder attributes to the early digitization pressure in this industry. This open-mindedness plays an important role in the success of EPD with patients. As pharmacists have refocused on their role as coaches and first responders, they have gained relevance as potentially important facilitators of EPD.

 

 

For the resident population, on the other hand, the result is somewhat different. Primarily, the EPD has not become better known over the past year, which may have to do with the waning media discussion of the topic, Golder suspects. The percentage of those in the resident population who think the EPD is a good thing in principle is 50%, and 19% even think it is a very good thing. However, when filtered by willingness to open an EPD, the number of open-minded people still currently shrinks to about one-third of the resident population (Fig. 2), with willingness higher among voters than among foreigners (33% vs. 8%). The population of French-speaking Switzerland is particularly motivated (45%) compared to German-speaking Swiss (29%) and to Italian-speaking parts of the population (23%).

 

 

The haptic driver for this development, according to Gilder, is the smartphone: the apps, which are used more widely, provide the impetus in the population, because these are very concretely applicable, while the benefit of an EPD is still a rather diffuse concept that exists only in theory. “However, a key driver is also the strategy – the EPDG. This is also the view of the cantonal eHealth managers we surveyed. In 2018, 26 cantonal managers participated in the survey. This full survey is a first.” In the meantime, the driving forces are an alliance of service providers, the cantonal authorities and parliaments. “It’s a powerful igniting effect,” Golder said.

The goal still seems a long way

The internal networking level concerns all services and information that are exchanged internally, the external ones those with service providers outside the institution. The interconnectedness index was defined on the basis of the OECD performance catalog. Internally, the index includes about half of all conceivable OECD services; thus, about 45% of the potential is being realized today across all surveyed service providers. In the hospitals surveyed, the figure is already very high at 75%. The value of the external networking index shows that there is still a long way to go to reach the target (19%) (Fig. 3).

 

 

The role of the medical profession

About three-quarters of those who could consider opening an EPD upon recommendation would prefer to receive that recommendation directly from a physician. This describes the important role of the physician as a catalyst. It is true that physicians tend to be somewhat more critical with regard to the form of the EPD and their willingness to pay. But if you ask the resident population who they would like to share their data with, the first place is always their treating physician. All other aspects in this context that are assessed as beneficial have less priority. The public is also making demands on the medical profession, such as online appointments or online consultations.

 

 

Benefit expectations and usage spiral

Interest in EPD on the part of the resident population is triggered by experience with apps for fitness and exercise. The majority knows these apps, 47% do not know them. Younger people still account for a higher proportion of app use than older people. App use is something 73% of the population can imagine or already uses. “If such use triggers positive feelings, new needs will soon arise. EPD data will certainly be accessible and usable via smartphone in the future. This will also create needs for new contexts of use,” was Golder’s optimistic forecast, and he elaborated: The study shows that there are already three positive benefit expectations among all healthcare providers and those entitled to vote, he said: Avoidance of treatment errors, avoidance of unnecessary treatment, and rapid data access for emergency treatment. The usage spiral – generating new usage expectations through positive usage experiences – will also continue to drive the use of EPD data, he said. This logic was already evident after the emergence of apps on smartphones, which are now embedded in the consumption and information behavior of their owners. The population expects insight into their own treatment information and the ability to add data themselves as well. Even if the first point is viewed somewhat more critically by the medical profession, such positive expectations of use will set in motion a spiral of innovation.

 

Further information and evaluations:
www.e-healthforum.ch

Contact details research institute
Luke Golder
gfs.berne
lukas.golder@gfsbern.ch

 

HAUSARZT PRAXIS 2018; 13(5): 37-39

Autoren
  • Karen Heidl
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • E-HEALTH
  • EPD
  • patient dossier
Previous Article
  • Brown Millet

Health benefits and questionable healing claims

  • General Internal Medicine
  • News
  • Pharmaceutical medicine
  • RX
View Post
Next Article
  • Arrhythmias

What is important to keep in mind for high-performance athletes?

  • Cardiology
  • Education
  • RX
  • Sports Medicine
View Post
You May Also Like
View Post
  • 16 min
  • Pain and autism

Hurdles to pain treatment for autistic patients

    • CME continuing education
    • Pediatrics
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 4 min
  • Pathophysiological mechanisms and therapeutic perspectives

Metabolic syndrome in patients with schizophrenia

    • Cardiology
    • Education
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 6 min
  • Hand eczema: from diagnosis to treatment

Implementing sustainable, stage-appropriate measures

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 4 min
  • Cystic fibrosis

Small spray – big footprint

    • Education
    • General Internal Medicine
    • Pediatrics
    • Pneumology
    • RX
    • Studies
View Post
  • 4 min
  • From symptom to diagnosis

Abdominal pain – Gastric outlet stenosis

    • Cases
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Radiology
    • RX
    • Surgery
View Post
  • 6 min
  • When the bones become more fragile: “Case Finding”

Fracture risk reduction in osteoporosis

    • Congress Reports
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Geriatrics
    • Rheumatology
    • RX
    • Studies
View Post
  • 6 min
  • Biologics for plaque psoriasis

What increases the chance of a sustained remission?

    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • RX
    • Studies
View Post
  • 12 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • CME continuing education
    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Hurdles to pain treatment for autistic patients
  • 2
    Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
  • 3
    Treatment of comorbidities in older people
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Rare malignancy from a dermatological perspective

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.